ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 86371 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 86371; 2) Community: the network communities that were significantly associated with the response to NSC 86371; 3) Molecule: the relationships between components within communities and NSC 86371; 4) MDR: the compounds that were significantly associated with the NSC 86371.

NSC Compound Enrichment Correlation
NSC 704614 Null 0.0112425217758227 0.37234472
NSC 706190 6H,14H-Benzo[b]naphtho[2,3-f][1,5]dithiocin-6,14-dione, 2-bromo- 0.0112425217758227 0.37860764
NSC 708822 Null 0.0112425217758227 0.27305238
NSC 716263 Null 0.0112425217758227 0.19385922
NSC 736200 6-(3-Bromopropyl)-5,6-dihydro3-nitro-5,11-dioxo-9-thiomethyl -11H-indeno[1,2-c]isoquinoline 0.0112425217758227 0.34936058
NSC 736493 Indenoisoquinoline derivative 0.0112425217758227 0.40964569
NSC 744331 (2R,11aS)-8- {2-[4-(2-{[(2R,11aS)-C2-di-Fluoro-7-Methoxy-5-oxo-2,3,5,11a-tetrahydro-1-H-benzo[e]-pyrrolo[1,2-a][1,4]diazepine-8-yl}propyl)piperazino]propoxy}-C2-di-fluoro-7-Methoxy-2,3,5,11a-tetrahyd 0.0112425217758227 0.44161359
NSC 732859 2-chloro-1-(benzenesulfonyl)piperidine-4-carboxilic acid biphenylamide. 0.0114553853234975 -0.057167585
NSC 100880 Camptothecin 0.0114553853234977 0.24900802
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0114553853234977 0.22840329
Total:139  Current:47    [First] [Prev] [Next] [Last]